Landmark NHS approval of cancer drugs offers new hope for children and adults with rare blood cancers

Infants and young children are among hundreds of patients set to receive new life-saving drugs for rare blood cancers. Around 200 patients a year will benefit from the 2 new cutting-edge treatments approved by NHS England, offering fresh hope to families when other therapies have failed. Dabrafenib is a tablet that treats histiocytic neoplasms – […]